Flexion Therapeutics (NASDAQ: FLXN) is a biopharmaceutical company focused on the discovery, development & commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions. Flexion is based in Burlington, Massachusetts. View our terms of use: https://flexiontherapeutics.com/terms-of-use/
View Top Employees from Flexion TherapeuticsWebsite | http://www.flexiontherapeutics.com |
Ticker | FLXN |
Revenue | $72 million |
Funding | $774.5 million |
Employees | 104 (104 on RocketReach) |
Founded | 2007 |
Address | 10 Mall Road Suite 301, Burlington, Massachusetts 01803, US |
Phone | (781) 305-7777 |
Fax | (781) 202-3399 |
Technologies |
JavaScript,
HTML,
PHP
+61 more
(view full list)
|
Industry | Biotechnology Research, Drug Manufacturing & Research, Biotechnology, Osteoarthritis, Pharmaceuticals, Science and Engineering, Pain Management, Healthcare, Health Care, Therapeutics |
Web Rank | 1 Million |
Keywords | Flexion Therapeutics, Flexion, Flexion Study Results, Michael Clayman Flexion, Flexion Therapeutics Burlington, Nc |
Competitors | AcelRx Pharmaceuticals, Adamas Pharmaceuticals, Inc., Dova Pharmaceuticals, Heron Therapeutics, Inc., Vanda Pharmaceuticals |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325413 Companies, NAICS Code 3254 Companies, NAICS Code 325414 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Flexion Therapeutics employee's phone or email?
The Flexion Therapeutics annual revenue was $72 million in 2024.
Melissa Layman is the Chief Commercial Officer of Flexion Therapeutics.
104 people are employed at Flexion Therapeutics.
Flexion Therapeutics is based in Burlington, Massachusetts.
The NAICS codes for Flexion Therapeutics are [325413, 3254, 325414, 325, 32541, 32].
The SIC codes for Flexion Therapeutics are [283, 28].